Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 195

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 4A
Chunk 195
---
17,958      $         (19,783  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Net cash provided by investing activities                                                                   18,682                 20,768  
  Net cash provided by financing activities                                                                    5,297                     25  
  Effect of exchange rate changes on cash, cash equivalents and restricted cash                                  (50                     57  
  Increase in cash, cash equivalents and restricted cash                             $                         5,971      $           1,067  

Net cash used in operating activities

The cash used in operating
activities resulted primarily from our net losses adjusted for non-cash charges and changes in components of working capital. Net cash
used in operating activities was $19,783 for the year ended December 31, 2024, compared to $17,958 for the year ended December 31, 2023.
The increase of $1,825 was primarily attributable to an increase in net loss of $2,593, a $1,700 decrease in non-cash financial expenses,
net, a $839 lower decrease in prepaid expenses and other receivables due in part to advance payments related to the construction of our
new manufacturing facility in Hudson, NH, and a $569 lower increase in other payables and accrued expenses, offset by an increase of $1,990
in share based compensation and a decrease of $1,774 in the change in fair value of warrants liabilities.

Net cash provided by investing activities

Net cash provided in investing
activities was $20,768 for the year ended December 31, 2024 compared to $18,682 for the year ended December 31, 2023. The increase in
cash provided from investing activities of $2,086 was primarily attributed to a $38,547 decrease in investment in short-term bank deposits
and a $4,163 decrease in purchase of property and equipment, offset by a decrease of $43,673 in proceeds from short-term bank deposits.

Net cash provided by financing activities

Net cash provided by financing
activities was $25 for the year ended December 31, 2024 compared to $5,297 for the year ended December 31, 2023. The decrease of $5,272
was primarily attributable to $5,248 bank loan proceeds received in October 2023.

Effect of exchange rate changes on cash, cash equivalents and
restricted cash

The effect of exchange rate
changes on cash